000 01572 a2200433 4500
005 20250513082703.0
264 0 _c19930709
008 199307s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19930615)71:12<4060::aid-cncr2820711242>3.0.co;2-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWaterhouse, D M
245 0 0 _aCombined carboplatin and cisplatin. Limited prospects for dose intensification.
_h[electronic resource]
260 _bCancer
_cJun 1993
300 _a4060-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCarboplatin
_xadministration & dosage
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aClinical Protocols
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHearing Loss
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aInjections, Intravenous
650 0 4 _aLeukopenia
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRemission Induction
650 0 4 _aThrombocytopenia
_xchemically induced
650 0 4 _aTime Factors
700 1 _aReynolds, R K
700 1 _aNatale, R B
773 0 _tCancer
_gvol. 71
_gno. 12
_gp. 4060-6
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19930615)71:12<4060::aid-cncr2820711242>3.0.co;2-0
_zAvailable from publisher's website
999 _c8507639
_d8507639